Average Co-Inventor Count = 10.93
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (27 from 822 patents)
2. Abbott Laboratories Corporation (17 from 4,179 patents)
3. Walter and Eliza Hall Institute of Medical Research (3 from 80 patents)
4. Genentech, Inc. (2 from 3,222 patents)
5. Abbvie Bahamas Limited (6 patents)
6. Abbvie Ireland Unlimited Company (0 patent)
44 patents:
1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
2. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
3. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use
4. 10081628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
5. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
6. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
7. 9493431 - Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
8. 9359296 - 7-substituted indole Mcl-1 inhibitors
9. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
13. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
14. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
15. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases